BACKGROUND: Changes in the methylation status of inflammatory bowel disease (IBD)-associated genes could significantly alter levels of gene expression, thereby contributing to disease onset and progression. We previously identified seven disease-associated DNA methylation loci from intestinal tissues of IBD patients using the Illumina GoldenGate BeadArray assay. AIMS: In this study, we extended this approach to identify IBD-associated changes in DNA methylation in B cells from 18 IBD patients [9 Crohn's disease (CD) and 9 ulcerative colitis (UC)]. B cell DNA methylation markers are particularly favorable for diagnosis due to the convenient access to peripheral blood. METHODS: We examined DNA methylation profiles of B cell lines using the Illumina GoldenGate BeadArray assay. Disease-associated CpGs/genes with changes in DNA methylation were identified by comparison of methylation profiles between B cell lines from IBD patients and their siblings without IBD. BeadArray data were validated using a bisulfite polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) method. To verify that observed changes in DNA methylation were not due to virus transformation, we compared specific CpG DNA methylation levels of GADD45A and POMC between B cell lines and matching peripheral blood B lymphocytes from five individuals. RESULTS: Using this approach with strict statistical analysis, we identified 11 IBD-associated CpG sites, 14 CD-specific CpG sites, and 24 UC-specific CpG sites with methylation changes in B cells. CONCLUSIONS: IBD- and subtype-specific changes in DNA methylation were identified in B cells from IBD patients. Many of these genes have important immune and inflammatory response functions including several loci within the interleukin (IL)-12/IL-23 pathway.

Department of Surgery College of Medicine The Pennsylvania State University 500 University Drive MC H 137 Hershey PA 17033 USA

See more in PubMed

Adv Exp Med Biol. 2006;579:149-67 PubMed

PLoS Genet. 2007 Sep;3(9):1709-23 PubMed

Nat Rev Genet. 2005 May;6(5):376-88 PubMed

Nat Genet. 2008 Aug;40(8):955-62 PubMed

Nat Rev Immunol. 2008 Jun;8(6):458-66 PubMed

Nat Genet. 2007 Jul;39(7):830-2 PubMed

Gut. 2007 Oct;56(10):1333-6 PubMed

J Gastroenterol. 2002 Nov;37 Suppl 14:97-101 PubMed

Immunity. 2002 Feb;16(2):219-30 PubMed

Hum Mol Genet. 2005 Nov 15;14(22):3499-506 PubMed

Nat Genet. 2007 Feb;39(2):207-11 PubMed

Hum Genet. 2010 Jun;127(6):651-8 PubMed

Genomics. 2010 Feb;95(2):73-83 PubMed

J Crohns Colitis. 2009 Sep;3(3):189-95 PubMed

Nat Genet. 2007 May;39(5):596-604 PubMed

Hum Mol Genet. 2009 Dec 15;18(24):4808-17 PubMed

Am J Hum Genet. 2009 Mar;84(3):399-405 PubMed

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):850-5 PubMed

Genome Res. 2006 Mar;16(3):383-93 PubMed

Semin Cancer Biol. 2009 Jun;19(3):158-64 PubMed

J Virol. 2004 Dec;78(24):14062-5 PubMed

Nature. 2007 Jun 7;447(7145):661-78 PubMed

Gastroenterology. 2004 Apr;126(4):1115-21 PubMed

Int Rev Immunol. 2004 May-Aug;23(3-4):315-31 PubMed

J Gastroenterol. 2006 May;41(5):401-7 PubMed

PLoS Biol. 2004 Dec;2(12):e405 PubMed

Inflammopharmacology. 2006 Dec;14(5-6):204-6 PubMed

Nat Genet. 2006 Dec;38(12):1378-85 PubMed

Science. 2006 Dec 1;314(5804):1461-3 PubMed

Nat Rev Immunol. 2008 Aug;8(8):631-43 PubMed

J Leukoc Biol. 2009 Oct;86(4):1007-16 PubMed

Clin Genet. 2011 Jul;80(1):59-67 PubMed

Int J Oncol. 2007 Jul;31(1):181-91 PubMed

DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis